Cargando…
Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series
INTRODUCTION: Approximately 15% (more than 2 million individuals, based on these estimates) of all people with diabetes will develop a lower-extremity ulcer during the course of the disease. Ultimately, between 14% and 20% of patients with lower-extremity diabetic ulcers will require amputation of t...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831833/ https://www.ncbi.nlm.nih.gov/pubmed/20181141 http://dx.doi.org/10.1186/1757-1626-3-54 |
_version_ | 1782178274851422208 |
---|---|
author | Blum, Kenneth Chen, Amanda LH Chen, Thomas JH Downs, B William Braverman, Eric R Kerner, Mallory Savarimuthu, Stella Bajaj, Anish Madigan, Margaret Blum, Seth H Reinl, Gary Giordano, John DiNubile, Nicholas |
author_facet | Blum, Kenneth Chen, Amanda LH Chen, Thomas JH Downs, B William Braverman, Eric R Kerner, Mallory Savarimuthu, Stella Bajaj, Anish Madigan, Margaret Blum, Seth H Reinl, Gary Giordano, John DiNubile, Nicholas |
author_sort | Blum, Kenneth |
collection | PubMed |
description | INTRODUCTION: Approximately 15% (more than 2 million individuals, based on these estimates) of all people with diabetes will develop a lower-extremity ulcer during the course of the disease. Ultimately, between 14% and 20% of patients with lower-extremity diabetic ulcers will require amputation of the affected limb. Analysis of the 1995 Medicare claims revealed that lower-extremity ulcer care accounted for $1.45 billion in Medicare costs. Therapies that promote rapid and complete healing and reduce the need for expensive surgical procedures would impact these costs substantially. One such example is the electrotherapeutic modality utilizing the H-Wave(® )device therapy and program. It has been recently shown in acute animal experiments that the H-Wave® device stimulation induces a nitric oxide-dependent increase in microcirculation of the rat Cremaster skeletal muscle. Moreover, chronic H-wave® device stimulation of rat hind limbs not only increases blood flow but induces measured angiogenesis. Coupling these findings strongly suggests that H-Wave® device stimulation promotes rapid and complete healing without need of expensive surgical procedures. CASE PRESENTATION: We decided to do a preliminary evaluation of the H-Wave(® )device therapy and program in three seriously afflicted diabetic patients. Patient 1 had chronic venous stasis for 6 years. Patient 2 had chronic recurrent leg ulcerations. Patient 3 had a chronic venous stasis ulcer for 2 years. All were dispensed a home H-Wave(® )unit. Patient 1 had no other treatment, patient 2 had H-Wave(® )therapy along with traditional compressive therapy, and patient 3 had no other therapy. For patient 1, following treatment the ulcer completely healed with the H-Wave(® )device and program after 3 months. For patient 2, by one month complete ulcer closure occurred. Patient 3 had a completely healed ulcer after 9 months. CONCLUSIONS: While most diabetic ulcers can be treated successfully on an outpatient basis, a significant proportion will persist and become infected. Based on this preliminary case series investigation we found that three patients prescribed H-Wave(® )home treatment demonstrate accelerated healing with excellent results. While these results are encouraging, additional large scale investigation is warranted before any interpretation is given to these interesting outcomes. |
format | Text |
id | pubmed-2831833 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28318332010-03-04 Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series Blum, Kenneth Chen, Amanda LH Chen, Thomas JH Downs, B William Braverman, Eric R Kerner, Mallory Savarimuthu, Stella Bajaj, Anish Madigan, Margaret Blum, Seth H Reinl, Gary Giordano, John DiNubile, Nicholas Cases J Case Report INTRODUCTION: Approximately 15% (more than 2 million individuals, based on these estimates) of all people with diabetes will develop a lower-extremity ulcer during the course of the disease. Ultimately, between 14% and 20% of patients with lower-extremity diabetic ulcers will require amputation of the affected limb. Analysis of the 1995 Medicare claims revealed that lower-extremity ulcer care accounted for $1.45 billion in Medicare costs. Therapies that promote rapid and complete healing and reduce the need for expensive surgical procedures would impact these costs substantially. One such example is the electrotherapeutic modality utilizing the H-Wave(® )device therapy and program. It has been recently shown in acute animal experiments that the H-Wave® device stimulation induces a nitric oxide-dependent increase in microcirculation of the rat Cremaster skeletal muscle. Moreover, chronic H-wave® device stimulation of rat hind limbs not only increases blood flow but induces measured angiogenesis. Coupling these findings strongly suggests that H-Wave® device stimulation promotes rapid and complete healing without need of expensive surgical procedures. CASE PRESENTATION: We decided to do a preliminary evaluation of the H-Wave(® )device therapy and program in three seriously afflicted diabetic patients. Patient 1 had chronic venous stasis for 6 years. Patient 2 had chronic recurrent leg ulcerations. Patient 3 had a chronic venous stasis ulcer for 2 years. All were dispensed a home H-Wave(® )unit. Patient 1 had no other treatment, patient 2 had H-Wave(® )therapy along with traditional compressive therapy, and patient 3 had no other therapy. For patient 1, following treatment the ulcer completely healed with the H-Wave(® )device and program after 3 months. For patient 2, by one month complete ulcer closure occurred. Patient 3 had a completely healed ulcer after 9 months. CONCLUSIONS: While most diabetic ulcers can be treated successfully on an outpatient basis, a significant proportion will persist and become infected. Based on this preliminary case series investigation we found that three patients prescribed H-Wave(® )home treatment demonstrate accelerated healing with excellent results. While these results are encouraging, additional large scale investigation is warranted before any interpretation is given to these interesting outcomes. BioMed Central 2010-02-10 /pmc/articles/PMC2831833/ /pubmed/20181141 http://dx.doi.org/10.1186/1757-1626-3-54 Text en Copyright ©2010 Blum et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Blum, Kenneth Chen, Amanda LH Chen, Thomas JH Downs, B William Braverman, Eric R Kerner, Mallory Savarimuthu, Stella Bajaj, Anish Madigan, Margaret Blum, Seth H Reinl, Gary Giordano, John DiNubile, Nicholas Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series |
title | Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series |
title_full | Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series |
title_fullStr | Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series |
title_full_unstemmed | Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series |
title_short | Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series |
title_sort | healing enhancement of chronic venous stasis ulcers utilizing h-wave(® )device therapy: a case series |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831833/ https://www.ncbi.nlm.nih.gov/pubmed/20181141 http://dx.doi.org/10.1186/1757-1626-3-54 |
work_keys_str_mv | AT blumkenneth healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries AT chenamandalh healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries AT chenthomasjh healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries AT downsbwilliam healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries AT bravermanericr healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries AT kernermallory healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries AT savarimuthustella healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries AT bajajanish healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries AT madiganmargaret healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries AT blumsethh healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries AT reinlgary healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries AT giordanojohn healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries AT dinubilenicholas healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries |